How AI Is Making an Impact on Clinical Trials

“Just like we simulate molecules and we simulate biology, what if we could simulate our trials before we run them?” In this clip from Recursion CEO and President Najat Khan, PhD's conversation with Selina Koch, PhD for the BioCentury Inc. Show, she talks about where AI is making an impact on clinical trials. 💠Recursion’s approach is focused in three areas, Najat says. 1. Improving patient stratification - “Can you improve the signal to noise to know which patients would better respond?” 2. Smarter protocol design and simulating the protocol. 3. Improving recruitment and enrollment. “80% of trials don’t recruit on time.” 👉 Watch the full conversation here: https://www.youtube.com/watch?v=LfGy7FvHk0A